Le Lézard
Classified in: Health
Subject: RCL

Food Recall Warning - Various poppy seeds recalled due to Salmonella


For more information: https://recalls-rappels.canada.ca/en/alert-recall/various-poppy-seeds-recalled-due-salmonella-1

OTTAWA, ON, April 20, 2022

Summary
Affected products

Brand

Product

Size

UPC

Codes

Distribution

None

Organic Poppy Seeds

Variable (sold in bulk)

None

All packages sold from April 2020 to April 13, 2022 inclusively

Sold at:

Bio Bazaar (Formerly 4 Life Natural Foods)

210 August Avenue,

Toronto (Ontario)

None

Poppy Seeds

Variable (sold in bulk)

None

All packages sold from December 2020 to April 13, 2022 inclusively

Sold at:

Nuthouse

1256 A Bloor St West,

Toronto (Ontario)

None

Organically Grown Poppy Seed

Variable (sold in bulk)

None

All packages sold from April 2020 to April 13, 2022 inclusively

Sold at:

Goodness Me! Natural Food Market (Formerly Noah's)

322 Bloor St. West,

Toronto (Ontario)

GPE

Organic Poppy Seeds

5 kg

0 57736 03042 9

Lot # 012220

Lot # 100520

Lot # 021721

Lot # 082421

Lot # 031622

Sold in Manitoba, Nova Scotia, Ontario, Quebec, Saskatchewan and sold at:

Grain Process Enterprises Ltd.

105 Commander Blvd, Scarborough (Ontario)

GPE

Organic Poppy Seeds

11.34 kg

0 57736 03040 5

Lot # 012220

Sold in Ontario

Issue

Industry is recalling various poppy seeds from the marketplace due to possible Salmonella contamination.

The recalled products have been sold as indicated in the table.

What you should do

Food contaminated with Salmonella may not look or smell spoiled but can still make you sick. Young children, pregnant women, the elderly and people with weakened immune systems may contract serious and sometimes deadly infections. Healthy people may experience short-term symptoms such as fever, headache, vomiting, nausea, abdominal cramps and diarrhea. Long-term complications may include severe arthritis.

Learn more:
Background

This recall was triggered by the Canadian Food Inspection Agency's inspection activities.

There have been no reported illnesses associated with the consumption of these products.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated food recall warnings.

The CFIA is verifying that industry is removing the recalled products from the marketplace.

Également disponible en français

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 00:01
America's child care supply remains flat, while child care prices continue to increase, according to a new report released today by Child Care Aware® of America (CCAoA) that highlights the burden families face accessing quality and affordable child...

at 00:01
The cost of living is Gen Zs' and millennials' top societal concern, but green shoots of optimism for the economy and their personal finances are emergingNearly nine in 10 Gen Zs and millennials say purpose is important to their job satisfaction and...

at 00:00
AmacaThera Inc, a clinical stage biotechnology company specializing in the development of advanced sustained release hydrogel formulations, has dosed its first human subject with AMT-143, the company's lead asset in non-opioid acute pain management. ...

14 mai 2024
BioArctic AB's (publ) partner Eisai today said that they expect Leqembi sales to total JPY 56.5 billion (approximately SEK 4 billion) for their fiscal year (FY) 2024 (April 2024 through March 2025). This would generate approximately SEK 360 M in net...

14 mai 2024
The global flow cytometry market  size is estimated to grow by USD 6038.44 million from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of about 13.12%  during the forecast period....

14 mai 2024
BioArctic AB's (publ) partner Eisai announced today that they have initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: Leqembi) subcutaneous...



News published on and distributed by: